Report ID: UCMIR35I2305
Report ID:
UCMIR35I2305 |
Region:
Regional |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
The 2022 valuation of the Asia Pacific dietary supplements market reached USD 57.25 billion, and it is projected to exhibit a compound annual growth rate (CAGR) of 12.6% from 2023 to 2030. The market's expansion can be attributed to several key factors, including heightened awareness of healthcare, a growing emphasis on preventive healthcare and tailored nutrition, and a shift towards self-directed health management due to an increasing focus on individual well-being. Additionally, the aging populations in many Asia Pacific countries have spurred a heightened demand for dietary supplements designed to address age-related health concerns like joint pain, cognitive decline, and cardiovascular issues.
This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.
Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.
The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Pharmaceuticals by segment aggregation, the contribution of the Pharmaceuticals in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.
To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONThe market for Asia Pacific Dietary Supplements was estimated to be valued at US$ XX Mn in 2021.
The Asia Pacific Dietary Supplements Market is estimated to grow at a CAGR of XX% by 2028.
The Asia Pacific Dietary Supplements Market is segmented on the basis of Ingredient Outlook, Form Outlook, Application Outlook, End-User Outlook, Type Outlook, Distribution Channel Outlook, Region/Country.
Based on region, the Asia Pacific Dietary Supplements Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
The key players operating in the Asia Pacific Dietary Supplements Market are Nestlé, Amway, Abbott, Bayer AG, Glanbia plc, Pfizer Inc., Archer Daniels Midland, GlaxoSmithKline plc., NU SKIN, Herbalife Nutrition, Otsuka Pharmaceutical Co., Ltd., Blackmores Limited, Bionova.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: UCMIR35I2305